Dr Reddy’s launches programme for IBS
Dr Reddy’s Laboratories Ltd, a city-based pharmaceutical company on Friday announced the roll-out of condition management programme DailyBloom IBS, a 14-week care plan for Irritable Bowel Syndrome (IBS)
image for illustrative purpose
Hyderabad: Dr Reddy’s Laboratories Ltd, a city-based pharmaceutical company on Friday announced the roll-out of condition management programme DailyBloom IBS, a 14-week care plan for Irritable Bowel Syndrome (IBS).
Launched on ‘World IBS Day’, the mobile application developed in-house, provides care plan that includes diet management, psychological and physical wellness support for patients with IBS.
M V Ramana, CEO, Branded Markets (India and Emerging Markets), Dr Reddy’s, said: “DailyBloom IBS has been developed in-house, based on research and consultation with experts including gastroenterologists. IBS is a chronic condition and its symptoms are often misdiagnosed or neglected. Our initiative is India’s first integrated care plan for IBS.”
The care plan begins with a DailyBloom Gut Health Index, an initial assessment that captures the frequency of symptoms and impact on quality of life. Following this assessment, patients engage in a goal-setting session, allowing for further personalisation of the care plan. In the 14-week journey, patients receive 16 consultations from a team of certified nutritionists, psychologists and care managers.
The programme also provides users with access to over 500 gut-friendly recipes based on Indian cuisine to help them manage their condition.
Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder characterised by abdominal pain, bloating and altered bowel habits. Citing studies Dr Reddy’s in an official release said that IBS leads to significant morbidity, work absenteeism, loss of productivity, economic burden to the society, and impacts the quality of life of patients. Around seven per cent of the Indian population suffers from IBS.
